(Q91552287)

English

Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance

scientific article published on 16 September 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Joseph R Grajo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Michael S Gee

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Alex Benjamin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Rebecca E Zubajlo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Kai E Thomenius

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Brian W Anthony

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Anthony E Samir

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

publication date

16 September 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

2461-2475

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The impact of sound speed errors on medical ultrasound imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Acoustic properties of normal and cancerous human liver-II. Dependence of tissue structure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Shear wave dispersion measures liver steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Mouse liver dispersion for the diagnosis of early-stage Fatty liver disease: a 70-sample study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Shear wave dispersion in lean versus steatotic rat livers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Backscatter coefficient imaging using a clinical scanner

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

NAFLD: a multisystem disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comprehensive compilation of empirical ultrasonic properties of mammalian tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Variation of ultrasound image lateral spectrum with assumed speed of sound and true scatterer density.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Repeatability and Reproducibility of a Clinically Based QUS Phantom Study and Methodologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Robust sound speed estimation for ultrasound-based hepatic steatosis assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Computed ultrasound tomography in echo mode for imaging speed of sound using pulse-echo sonography: proof of principle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasound in the detection of chronic liver disease (the “bright liver”)

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Secondary causes of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A new method for measuring the speed of sound in rat liver ex vivo using an ultrasound system: correlation of sound speed with fat deposition

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Correlation of Fourier spectral shift-determined hepatic acoustic attenuation coefficients with liver biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Estimating the total ultrasound attenuation along the propagation path by applying multiple filters to backscattered echoes from a single spherically focused source

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A theoretical comparison of attenuation measurement techniques from backscattered ultrasound echoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Radiologic evaluation of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Correlations of sound speed with tissue constituents in normal and diffuse liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The global NAFLD epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasound backscatter and attenuation in human liver with diffuse disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Detecting hepatic steatosis using ultrasound-induced thermal strain imaging: an ex vivo animal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Attenuation of ultrasound in normal liver and diffuse liver disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

An evaluation of hepatic ultrasound speed in injury models in rats: correlation with tissue constituents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comparison of ultrasound attenuation and backscatter estimates in layered tissue-mimicking phantoms among three clinical scanners

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Sound speed correction in ultrasound imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Phase aberration correction in medical ultrasound using speckle brightness as a quality factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonic propagation properties (@ 100 MHz) in excessively fatty rat liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Principles of ultrasound elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

In-vivo measurements of ultrasound attenuation in normal or diseased liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Pulse-echo ultrasound speed measurements: progress and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Donor selection for adult-to-adult living donor liver transplantation: well begun is half done

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive diagnosis of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Interobserver and intraobserver variability in the sonographic assessment of fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver glycogen and water storage: effect on ultrasound attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Backscatter coefficient measurements using a reference phantom to extract depth-dependent instrumentation factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Hepatitis C virus (HCV) infection and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative ultrasound imaging: in vivo results in normal liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Identifiers

10.1016/J.ULTRASMEDBIO.2018.07.019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91552287&oldid=2034710258"